Pharma comanies can’t sell tweaked drugs under old brand name

The issue has been discussed for years now, and was deliberated in several Drugs Consultative Committee meetings held since 2008.

from Industry-Economic Times http://bit.ly/2Hv83Rl
via IFTTT